{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:21:35Z","timestamp":1758709295414,"version":"3.40.5"},"reference-count":11,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Respiratory mucosal infection by airborne microbes is a common event that occurs every day. We report here that intranasal administration of non-replicating adenovirus (Ad) particles to mice could either confer rapid protection against influenza virus (IFV) challenge independent of adaptive immunity, or exacerbate influenza by triggering rapid death. The life-or-death outcome hinges on the time interval between Ad administration and IFV challenge in conjunction with specific mouse\/IFV strains. Intranasal instillation of Ad particles 1\u201347 days prior to IFV challenge conferred rapid protection against influenza in Balb\/c mice whereas exposure to Ad 39 days prior to challenge with a specific IFV strain or 1 day post-challenge with that IFV strain induced rapid death in C57BL\/6 mice. Notably, consecutive administrations of Ad prior to IFV challenge conferred a synergy in triggering a potent anti-influenza state; even a detrimental Ad exposure 39 days before challenge with the deadly IFV strain was reversed to a beneficial one by subsequent Ad boosts. Results revealed an intricate relationship between infection and innate immunity that is a linchpin around which effects revolve from protective immunity to collateral damage. It is urgent to repeat the experiments with an expanded scope for characterizing the status that defines susceptibility or resistance to IFV infection and subsequently reveal the underlying mechanisms. Whether broad heterologous protective effects induced by AdE and adaptive immunity elicited by vaccination could confer synergy during mitigation of a pandemic remains to be seen.<\/jats:p>","DOI":"10.1371\/journal.pone.0241266","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T18:43:32Z","timestamp":1605206612000},"page":"e0241266","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Paradoxical modulation of influenza by intranasal administration of non-replicating adenovirus particles"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3813-9238","authenticated-orcid":true,"given":"De-chu Christopher","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"pone.0241266.ref001","doi-asserted-by":"crossref","first-page":"e22605","DOI":"10.1371\/journal.pone.0022605","article-title":"Adenovirus-vectored drug-vaccine duo as a rapid-response tool for conferring seamless protection against influenza","volume":"6","author":"J Zhang","year":"2011","journal-title":"PLOS ONE"},{"key":"pone.0241266.ref002","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.aaz9447","article-title":"Vaccination Strategies to Enhance Immunity in Neonates","volume":"368","author":"TR Kollmann","year":"2020","journal-title":"Science"},{"key":"pone.0241266.ref003","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1586\/erv.11.141","article-title":"Adenovirus-vectored drug-vaccine duo as a potential driver for conferring mass-protection against infectious diseases","volume":"10","author":"J Zhang","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"pone.0241266.ref004","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.vaccine.2004.07.043","article-title":"Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans","volume":"23","author":"KR Van Kampen","year":"2005","journal-title":"Vaccine"},{"key":"pone.0241266.ref005","doi-asserted-by":"crossref","first-page":"12713","DOI":"10.1128\/JVI.01675-10","article-title":"MyD88 signaling is indispensable for primary influenza A virus infection but dispensable for secondary infection","volume":"84","author":"SU Seo","year":"2010","journal-title":"J Virol"},{"key":"pone.0241266.ref006","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/CVI.00341-10","article-title":"Sublingual administration of an adenovirus serotype 5 (Ad5)-based vaccine confirms Toll-like receptor agonist activity in the oral cavity and elicits improved mucosal and systemic cell-mediated responses against HIV antigens despite preexisting Ad5 immunity","volume":"18","author":"DM Appledorn","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"pone.0241266.ref007","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1523-1747.2003.12327.x","article-title":"Comparative proteomic profiling of murine skin","volume":"121","author":"CM Huang","year":"2003","journal-title":"J Invest Derm"},{"key":"pone.0241266.ref008","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1165\/rcmb.2013-0086MA","article-title":"Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung","volume":"49","author":"AV Misharin","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"pone.0241266.ref009","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"PM Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"pone.0241266.ref010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neulet.2019.04.035","article-title":"Rapamycin relieves inflammation of experimental autoimmune encephalomyelitis by altering the balance of Treg\/Th17 in a mouse model","volume":"705","author":"Z Li","year":"2019","journal-title":"Neurosci Lett"},{"key":"pone.0241266.ref011","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1124\/jpet.103.053819","article-title":"Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma","volume":"307","author":"RK Kumar","year":"2003","journal-title":"J Pharmacol Exp Ther"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0241266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T18:43:45Z","timestamp":1605206625000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0241266"}},"subtitle":[],"editor":[{"given":"Mrinmoy","family":"Sanyal","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":11,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0241266","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,11,12]]}}}